Mexico vs Panama: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Mexico
78.0%
in 2025
Panama
77.0%
in 2025
Mexico rank
123rd
Panama rank
124th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Mexico
- Panama
How they compare
Mexico currently reports 78.0% against 77.0% in Panama, a difference of 1.0%.
The two have swapped places 8 times across 18 shared years of data; in 2008 it was Mexico ahead.
Mexico ranks 123rd and Panama ranks 124th of 194 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Panama in 1.
Head to head by decade
| Decade | Mexico | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 0.0% | 30.0% | Mexico |
| 2010s | 91.8% | 84.2% | 7.6% | Mexico |
| 2020s | 79.3% | 80.7% | 1.3% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Mexico or Panama?
- Mexico, at 78.0% against 77.0% in Panama as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Mexico and Panama?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Panama?
- 18 years are reported by both, from 2008 to 2025.
- How do Mexico and Panama rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Mexico ranks 123rd and Panama ranks 124th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.